Tuesday, February 15, 2022

< + > The Road To 340B Was Paved With Good Intentions So Why Are Drug Companies Looking For An Off Ramp?

From a $5 billion program in 2014 to a $30 billion program in 2019, 340B saw a 47% compound annual growth rate in five years, significantly outpacing other government pricing programs. Current estimates place it at about $34 billion today.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Bonus Features – August 9, 2026 – 57% of home- and community-based providers evaluating AI tools, 28% of patients have put off canceling an appointment because it required a phone call, plus 25 more stories

Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...